Selinexor: Additional Phase II data

Data from 27 evaluable patients with recurrent GBM who were previously treated with radiotherapy

Read the full 144 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE